IBSP and prostate carcinoma: Given that αvβ3 and BSP are co-expressed in prostate cancer cell lines (47) and primary breast invasive ductal carcinoma samples (21), the binding of BSP to integrins may contribute to tumour progression by connecting cancer cells to the ECM and activating downstream signalling pathways.